Entwodiksyon ak aplikasyon CAS:482-36-0|Hyperoside
Itilize pou detèminasyon kontni / idantifikasyon / eksperyans famasi, elatriye Efè famasi: 1. Hypericin gen efè analgesic lokal enpòtan. Efè analgesic la pi fèb pase morfin, pi fò pase aspirin, epi li pa gen okenn depandans. Li se yon nouvo kalite analgesic lokal. 2. Hypericin gen Chemicalbook montre bon efè pwoteksyon sou myokad ischemi reperfusion, serebral ischemi reperfusion, ak enfaktis serebral. 3. Hypericin gen efè anti-enflamatwa evidan. 4. Li gen gwo efè antitussif. 5. Li gen yon gwo efè inhibition sou okilè aldoz reduktaz, ki ka benefisye pou anpeche katarak dyabetik.
Spesifikasyon CAS:482-36-0|Hyperoside
| Atik | Spesifikasyon |
Pwen k ap fonn: 225-226 degre
Pwen bouyi: 872.6±65.0 degre (Prevwa)
Dansite: 1.87±0.1g/cm3 (Prevwa)
Kondisyon depo: -20 degre
Solibilite: idrosolubl nan DMSO (yon ti kras), metanol (yon ti kras, chofaj)
Koyefisyan asidite (pKa): 6.17± 0.40 (Prevwa)
Fòm: solid
Koulè: jòn limyè a jòn epè
Pake ak transpò CAS:482-36-0|Hyperoside
Pake: 20mg, 50mg, 1g;
Transpò: pa courrier / pa lè / pa lanmè.
Atik ki gen rapò ak CAS:482-36-0|Hyperoside
Hyperoside: Yon revizyon sou sous li yo, aktivite byolojik, ak mekanis molekilè
Q Wang, HC Wei, SJ Zhou, Y Li, TT Zheng… - Fitoterapi …, 2022 - Wiley Online Library
Aktivite farmakolojik ak etid farmakokinetik nan hyperoside: Yon revizyon kout
A Raza, X Xu, H Solèy, J Tang, Z Ouyang - Twopikal Journal of …, 2017 - ajol.info
Baj popilè: cas:482-36-0|hyperoside, Lachin cas:482-36-0|Hyperoside manifaktirè, faktori








![CAS:147489-06-3|T-Butil (3R,5S)-7-[2-cyclopropyl-4-({4-fluorophenyl)quinolin-3-il]-3,{{10 }}isopropylidenedioxy-6-eptenoat](/uploads/202340266/small/cas-147489-06-3-t-butyl-3r-5s-7-2-cyclopropyl0e52c1ae-0244-4d32-aaa5-299cfa1e43d9.jpg?size=195x0)

![CAS: 2136287-66-4|7,8-difluorodibenzo[b,e]thiepin-11(6H)-yon sèl Zofluza Entèmedyè](/uploads/202340266/small/cas-2136287-66-4-7-8-difluorodibenzo-b-ef9c07643-5b9c-4816-afa0-ab833b42584f.png?size=195x0)
